Dubuque Bank & Trust Co. Invests $304,000 in Aphria Inc (NYSE:APHA)
Dubuque Bank & Trust Co. acquired a new position in shares of Aphria Inc (NYSE:APHA) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 58,170 shares of the company’s stock, valued at approximately $304,000.
Several other large investors have also recently bought and sold shares of the stock. Tower Research Capital LLC TRC boosted its holdings in Aphria by 76.0% during the second quarter. Tower Research Capital LLC TRC now owns 6,248 shares of the company’s stock worth $44,000 after purchasing an additional 2,698 shares during the last quarter. First Allied Advisory Services Inc. acquired a new stake in Aphria in the 3rd quarter valued at $57,000. Wedbush Securities Inc. increased its stake in Aphria by 40.6% in the 3rd quarter. Wedbush Securities Inc. now owns 15,070 shares of the company’s stock valued at $78,000 after buying an additional 4,350 shares during the last quarter. Signition LP bought a new stake in Aphria during the 3rd quarter worth about $86,000. Finally, Virtu Financial LLC lifted its position in Aphria by 14.9% during the 3rd quarter. Virtu Financial LLC now owns 18,365 shares of the company’s stock worth $95,000 after buying an additional 2,380 shares in the last quarter. Institutional investors and hedge funds own 9.60% of the company’s stock.
Several equities analysts have recently weighed in on APHA shares. ValuEngine cut Aphria from a “buy” rating to a “hold” rating in a report on Thursday, December 5th. Bank of America began coverage on Aphria in a research report on Monday. They set a “neutral” rating for the company. Jefferies Financial Group set a $8.30 price target on Aphria and gave the company a “buy” rating in a research note on Tuesday, October 15th. Cantor Fitzgerald initiated coverage on Aphria in a research report on Tuesday, November 5th. They set an “overweight” rating and a $10.40 price target on the stock. Finally, CIBC raised Aphria from an “underperform” rating to a “hold” rating and set a $7.00 price target on the stock in a research report on Tuesday. Four investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Aphria presently has an average rating of “Buy” and an average target price of $12.09.
Aphria (NYSE:APHA) last announced its quarterly earnings data on Tuesday, October 15th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.10. The business had revenue of $126.10 million for the quarter, compared to the consensus estimate of $131.15 million. The business’s quarterly revenue was up 848.1% on a year-over-year basis. As a group, sell-side analysts predict that Aphria Inc will post 0.06 EPS for the current fiscal year.
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.
Want to see what other hedge funds are holding APHA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aphria Inc (NYSE:APHA).
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.